|
Charlie Evavold
Immunology, Jonathan Kagan lab
Charlie Evavold grew up in Atlanta, GA. He graduated in May 2013 with a Bachelor of Science with highest honors from Emory University where he majored in both physics and chemistry. After graduation, he transitioned into biology research through an Oak Ridge Institute for Science and Education (ORISE) fellowship to work in the Q fever group at the Center for Disease Control and Prevention (CDC). After exposure to microbiology and infection biology, Charlie decided to pursue a PhD in Immunology to study complex signal processing in immune cells. Charlie joined the lab of Jon Kagan to study the tug-of-war between pro-survival signaling pathways and programs of cell death. He is currently investigating a somatic mutation found in the signaling adaptor MyD88 that causes aberrant toll-like receptor (TLR) signaling from endosomes that constitutes a pro-survival signal in certain B cell lymphomas. He is also investigating negative regulators of an inflammatory program of cell death, known as pyroptosis. His dissertation will focus on how pro-survival pathways and programs of cell death intersect to determine cancer and immune cell fate.
|
|
Eran Hodis
Biophysics, Levi Garraway and Aviv Regev labs
Eran Hodis was born in Haifa, Israel and grew up in Framingham, Massachusetts. He pursued his interest in science and math as a University Scholar at Boston University, graduating in 2007 with a dual major Mathematics and in Biochemistry/Molecular Biology. Afterwards, he trained in computational biology at the Weizmann Institute of Science in Israel, earning an M.Sc. in 2010. When his mother was diagnosed with cancer, he dedicated himself to cancer research. At Harvard, Eran’s work in cancer genomics has contributed to our understanding of the genetic underpinnings of melanoma, the most lethal form of skin cancer. His current research seeks to better understand the disease by asking how mutations cooperate to make a melanoma. He co-teaches a highly-rated course on RNA-sequencing analysis in the Department of Stem Cell and Regenerative Biology: SCRB 152. Eran is a 2016 Paul & Daisy Soros Fellow and was listed among the Forbes ’30 Under 30’ in Science in 2015.
|
|
Haley Manchester
Biological and Biomedical Sciences, Karen Cichowski lab
Haley Manchester was born in Providence, RI. In 2012, she graduated summa cum laude from Bates College with a B.S. in Biological Chemistry and minor in mathematics. During her time at Bates, she sang soprano in an all-female a capella group and studied traditional medicine in China and Vietnam for a semester. She first discovered her love of research after interning in a lab that developed small molecule inhibitors for Yersinia pestis, the bacteria behind the bubonic plague. After graduating from Bates, she worked as a research associate at the Dana-Farber Cancer Institute examining the role of a chromatin remodeling complex in cancer. She joined Dr. Karen Cichowski's lab in 2015 to study novel therapies for melanoma that target signaling pathways and important epigenetic regulators.
|
|
Roo St. Pierre
Chemical Biology, Cigall Kadoch lab
Roodolph St Pierre (Roo) was born and raised in Port au Prince, Haiti. He graduated from the University of Massachusetts Boston with a Bachelor in Chemistry with Honors in 2011. During his undergraduate, Roo landed an internship at the Broad Institute in the lab of Dr. Stuart Schreiber where he gained a foundational introduction to structural biology. Following graduation, Roo transitioned to the lab of Dr. James Bradner at the Dana Farber Cancer Institute where he applied his structural biology toolkit to the art of cancer drug discovery. Now in the lab of Dr. Cigall Kadoch at Harvard, he is investigating the implication of SMARCE1 in the genesis of meningioma, which represents a third of all tumors that arise within the central nervous system. Beyond the lab, Roo serves as a mentor and advisory member to the Dana Farber/Harvard Cancer Center CURE program to expose a greater number of under-represented High School and College students to cancer research. On campus, Roo is the co-president of MBSH, a student group dedicated to fostering an environment conducive to the promotion of minority groups within academia.
|
|
Katie Weiner
Molecules, Cells and Organisms, Fred Winston Lab, formerly John Rinn lab
Catherine Weiner (Katie) was raised in Briarcliff Manor, New York. She graduated magna cum laude from the University of Rochester in 2014, with a major in Biochemistry and a minor in Mathematics. She is a member of Phi Beta Kappa. In addition to her rigorous academics, Katie was a four-year member of the Women’s Basketball team, earning Academic all-conference honors in the three years she was eligible and playing in the NCAA tournament twice. At Harvard, she currently works in the lab of John Rinn, where her work focuses on understanding the three dimensional organization of the genome using novel live-cell imaging techniques. She is particularly interested in the role noncoding RNAs play in mediating these interactions. Dr. John Rinn is currently located at University of Colorado Boulder. John was supportive of Katie's decision to switch to the Winston lab so she could continue her PhD at Harvard. In the Winston lab, she researches the role of the highly conserved histone chaperone Spt6 on genome instability - a hallmark of human cancers.
|
